Our work revealed the critical role of MUSTN1 in regulating adipogenesis by interacting with FABP3 and activating the PI3K/AKT signaling pathway, providing a theoretical foundation and a potential molecular target for improving animal performance and treating obesity-related diseases. Here, AKT1 is linked to obesity disorder.